Euroclone will sell Precipio's Ice Cold-PCR DNA enrichment products for use with liquid biopsies exclusively in Italy and non-exclusively in the rest of Europe.
Pro-Lab will shepherd Medicortex's kit through the regulatory processes in Canada and the UK, as well as clinically validate it. It will have exclusive rights to sell the kit in the two nations.
Malaysia-based ScienceVision has agreed to commercialize and distribute the PierianDx Clinical Genomics Workspace platform in Southeast Asian countries.
Ortho said it will initially launch Sentinel's wide-range C-reactive protein assay in North America, Europe, Africa, and the Middle East.
The deal covers IncellDx's portfolio of immune-oncology and oncology diagnostic products including its single-cell assay for quantifying PD-L1 on tumor cells and immune cell subtypes.
The deals cover Plexbio's IntelliPlex 1000 πCode Processor and the PlexBio 100 Fluorescent Analyzer for the IVD and life science research markets.
The CE-marked test detects two biomarkers of infection in peritoneal dialysis waste fluid using a lateral flow immunoassay system.
The deal covers SpeeDx's line of multiplexed PlexPCR and ResistancePlus tests in the UK and Ireland.
A brief recap of Diagnostics news the week of Apr 20, 2018: Boston Scientific, Interpace, Human Longevity, CareDX, OpGen SeraCare Life Sciences, Omega Diagnostics, MDxHealth's SelectMDx.
The companies are aiming to develop and establish clinical operation for the assays in Japan, where Hitachi said there is growing demand for such tests.